ADMA Biologics, Inc. (ADMA)
13.67
+0.43
(+3.25%)
USD |
NASDAQ |
Nov 13, 16:00
13.67
0.00 (0.00%)
After-Hours: 19:59
ADMA Biologics Total Liabilities (Quarterly) : 293.98M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 293.98M |
| June 30, 2026 | 276.00M |
| March 31, 2026 | 274.86M |
| December 31, 2025 | 156.03M |
| September 30, 2025 | 137.50M |
| June 30, 2025 | 160.06M |
| March 31, 2025 | 137.15M |
| December 31, 2024 | 149.36M |
| September 30, 2024 | 158.73M |
| June 30, 2024 | 188.13M |
| March 31, 2024 | 197.17M |
| December 31, 2023 | 193.98M |
| September 30, 2023 | 197.56M |
| June 30, 2023 | 196.26M |
| March 31, 2023 | 195.13M |
| December 31, 2022 | 196.49M |
| September 30, 2022 | 200.17M |
| June 30, 2022 | 182.53M |
| March 31, 2022 | 181.10M |
| December 31, 2021 | 135.08M |
| September 30, 2021 | 135.86M |
| June 30, 2021 | 121.22M |
| March 31, 2021 | 123.16M |
| December 31, 2020 | 119.42M |
| September 30, 2020 | 118.60M |
| Date | Value |
|---|---|
| June 30, 2020 | 114.66M |
| March 31, 2020 | 114.19M |
| December 31, 2019 | 100.90M |
| September 30, 2019 | 101.66M |
| June 30, 2019 | 96.37M |
| March 31, 2019 | 68.08M |
| December 31, 2018 | 69.11M |
| September 30, 2018 | 69.14M |
| June 30, 2018 | 65.99M |
| March 31, 2018 | 68.11M |
| December 31, 2017 | 67.69M |
| September 30, 2017 | 59.82M |
| June 30, 2017 | 56.96M |
| March 31, 2017 | 28.35M |
| December 31, 2016 | 28.14M |
| September 30, 2016 | 27.65M |
| June 30, 2016 | 27.83M |
| March 31, 2016 | 23.05M |
| December 31, 2015 | 22.89M |
| September 30, 2015 | 22.91M |
| June 30, 2015 | 20.28M |
| March 31, 2015 | 20.50M |
| December 31, 2014 | 21.22M |
| September 30, 2014 | 16.04M |
| June 30, 2014 | 15.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| BioMarin Pharmaceutical, Inc. | 5.313B |
| Nektar Therapeutics | 192.01M |
| Rhythm Pharmaceuticals, Inc. | 241.59M |
| Arcutis Biotherapeutics, Inc. | 280.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 732.48M |
| Shareholders Equity (Quarterly) | 438.51M |
| Debt to Equity Ratio | 0.4625 |
| Current Ratio | 6.044 |
| Net Debt Paydown Yield | -1.06% |